CSTONE PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of 2616 for the last semiannual is 275.42 M HKD, and it's 25.98% higher compared to the previous semiannual. The net income of H1 24 is 17.01 M HKD.